23 related articles for article (PubMed ID: 2899159)
1. Prolactin and fMRI response to SKF38393 in the baboon.
Miller B; Marks LA; Koller JM; Newman BJ; Bretthorst GL; Black KJ
PeerJ; 2013; 1():e195. PubMed ID: 24255811
[TBL] [Abstract][Full Text] [Related]
2. Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies.
Jackson DM; Mohell N; Georgiev J; Bengtsson A; Larsson LG; Magnusson O; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):146-55. PubMed ID: 7539523
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists.
Jackson DM; Ross SB; Edwards SR
J Neural Transm; 1989; 75(3):213-20. PubMed ID: 2784489
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study.
Jackson DM; Ross SB; Larsson LG
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842
[TBL] [Abstract][Full Text] [Related]
5. Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine.
Jackson DM; Martin LP; Larsson LG; Cox RF; Waszczak BL; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):290-9. PubMed ID: 2126347
[TBL] [Abstract][Full Text] [Related]
6. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.
Löschmann PA; Smith LA; Lange KW; Jaehnig P; Jenner P; Marsden CD
Psychopharmacology (Berl); 1991; 105(3):303-9. PubMed ID: 1686813
[TBL] [Abstract][Full Text] [Related]
7. The motor effects of bromocriptine--a review.
Jackson DM; Jenkins OF; Ross SB
Psychopharmacology (Berl); 1988; 95(4):433-46. PubMed ID: 3145515
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-mediated behaviours produced in naive mice by bromocriptine plus SKF 38393.
Jackson DM; Ross SB; Hashizume M
J Pharm Pharmacol; 1988 Mar; 40(3):221-3. PubMed ID: 2899159
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
Jackson DM; Hashizume M
Psychopharmacology (Berl); 1986; 90(1):147-9. PubMed ID: 3094056
[TBL] [Abstract][Full Text] [Related]
10. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
Jackson DM; Ross SB; Hashizume M
Psychopharmacology (Berl); 1988; 94(3):321-7. PubMed ID: 2895938
[TBL] [Abstract][Full Text] [Related]
11. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
Vasse M; Chagraoui A; Protais P
Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors.
Jackson DM; Hashizume M
J Neural Transm; 1987; 69(1-2):131-45. PubMed ID: 2953861
[TBL] [Abstract][Full Text] [Related]
13. Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393.
Meltzer LT; Wiley JN; Williams AE; Heffner TG
Psychopharmacology (Berl); 1988; 95(3):329-32. PubMed ID: 2901126
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
